Search Results - "Boulton Jones, M"

Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units by Stirling, C.M., Mathieson, P., Boulton-Jones, J.M., Feehally, J., Jayne, D., Murray, H.M., Adu, D.

“…Background: Focal segmental glomerulosclerosis (FSGS) is the least studied of the causes of idiopathic nephrotic syndrome, and there are few specific…”
Get full text

Presentation, survival and prognostic markers in AA amyloidosis by Joss, N., McLaughlin, K., Simpson, K., Boulton‐Jones, J.M.

“…We reviewed 43 patients with AA amyloidosis who presented to our unit between 1985–1999: 70% had an underlying chronic rheumatological diagnosis. Median (95%…”
Get full text

Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy by Harden, P N, Geddes, C, Rowe, P A, McIlroy, J H, Boulton-Jones, M, Rodger, R S, Junor, B J, Briggs, J D, Connell, J M, Jardine, A G

“…We have investigated the influence of the functional insertion (I) and deletion (D) polymorphism in intron 16 of the gene for angiotensin-converting enzyme…”
Get more information

Intensified treatment of patients with type 2 diabetes mellitus and overt nephropathy by Joss, N., Ferguson, C., Brown, C., Deighan, C.J., Paterson, K.R., Boulton-Jones, J.M.

“…Background: Diabetic nephropathy is the single most common cause of chronic renal failure requiring dialysis. Effective treatment exists, but no clinical audit…”
Get full text

Exercise during haemodialysis: West of Scotland pilot study by Moug, S J, Grant, S, Creed, G, Boulton Jones, M

“…Exercise during dialysis (EDD) in End-Stage Renal Disease (ESRD) has been documented as an effective intervention to improving a patient's aerobic capacity…”
Get more information

The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis by Mackinnon, B, Deighan, C J, Norrie, J, Boulton-Jones, J M, Sattar, N, Fox, J G

“…It is well established that there is an increase in the incidence of cardiovascular mortality in patients with proteinuric renal disease. The magnitude of the…”
Get more information

An artificial neural network can select patients at high risk of developing progressive IgA nephropathy more accurately than experienced nephrologists by Geddes, Colin C., Fox, Jonathan G., Allison, Marjory E. M., Boulton-Jones, J. Michael, Simpson, Keith

“…Background. The object of the study was to develop an artificial neural network (ANN) to identify patients with IgA nephropathy (IgAN) with a poor prognosis…”
Get full text

Diabetic nephropathy: how effective is treatment in clinical practice? by Joss, N., Paterson, K.R., Deighan, C.J., Simpson, K., Boulton‐Jones, J.M.

“…Background: Diabetic nephropathy is the most common cause of end‐stage renal failure in patients starting dialysis in the developed world. In clinical trials,…”
Get full text

The perioperative challenge of nephrogenic diabetes insipidus: A multidisciplinary approach by Moug, S.J., McKee, R.F., O’Reilly, D.St.J., Noble, S., Boulton-Jones, M.

“…Nephrogenic Diabetes Insipidus (NDI) is characterised by the inability of the kidneys to concentrate urine in response to arginine vasopressin (AVP). Such…”
Get full text

Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation by Deighan, Christopher J., Caslake, Muriel J., McConnell, Michael, Boulton-Jones, J.Michael, Packard, Christopher J.

“…End-stage renal failure (ESRF) is associated with dyslipidemia and accelerated atherosclerosis. Triglyceride-rich lipoproteins accumulate and qualitative…”
Get full text

Progressive oedema in a 30-year-old by Stirling, CM, Boulton-Jones, JM, Simpson, K

“…Stirling and Boulton discuss the case of a 30-year-old woman who presented to hospital with an 8-week history of progressive oedema. The woman was diagnosed…”
Get full text

Immunosuppression and outcome in idiopathic membranous nephropathy by STIRLING, C. M, SIMPSON, K, BOULTON-JONES, J. M

“…From 1986 to 1996, 53 patients with idiopathic membranous nephropathy (IMN) presented to the Glasgow Royal Infirmary renal unit: 19 (36%) were treated because…”
Get full text

Glomerular charge selectivity in type 1 (insulin-dependent) diabetes mellitus by Fox, J G, Quin, J D, Paterson, K R, O'Reilly, D S, Smith, M P, Boulton-Jones, J M

“…Glomerular charge selectivity was assessed using the ratio of the clearance of pancreatic isoamylase to the clearance of the more anionic salivary isoamylase…”
Get more information

Post-prandial lipoprotein metabolism in nephrotic syndrome by Warwick, G L, Packard, C J, Stewart, J P, Watson, T D, Burns, L, Boulton-Jones, J M, Shepherd, J

“…Post-prandial lipaemia was investigated in a group of nine subjects with nephrotic syndrome by following the concentrations of triglyceride and retinyl…”
Get more information

Exacerbation of lupus nephritis in association with leuprorelin injection for uterine leiomyoma by METCALFE, W, BOULTON-JONES, J. M

Get full text

Urinary transferrin, high molecular weight proteinuria and the progression of renal disease by Mackinnon, B, Shakerdi, L, Deighan, C J, Fox, J G, O'Reilly, D St J, Boulton-Jones, M

“…Proteinuria predicts rate of progression in a variety of nephropathies. There is considerable evidence that iron-transferrin is toxic to proximal tubular cells…”
Get more information

Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1 by Deighan, Christopher J., Caslake, Muriel J., Mcconnell, Michael, Boulton-Jones, J. Michael, Packard, Christopher J.

“…Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1. Impaired very low-density lipoprotein (VLDL) clearance contributes to…”
Get full text

Meloxicam pharmacokinetics in renal impairment by BOULTON-JONES, J. M, GEDDES, C. G, HEINZEL, G, TÜRCK, D, NEHMIZ, G, BEVIS, P. J. R

“…The aim of the present study was to determine how the pharmacokinetics of meloxicam are affected by kidney dysfunction and consequently to define the…”
Get full text

The hypertensive young lady with renal cysts—it is not always polycystic kidney disease by McLaughlin, Kevin, Neilly, J. Brian, Fox, Jonathan G., Boulton‐Jones, J. Michael

Get full text

Diabetic nephropathy : an observational study on patients attending a joint diabetes renal clinic by LIEW, B. S, PERRY, C, BOULTON-JONES, J. M, SIMPSON, K, PATERSON, K

“…Diabetic nephropathy is a major cause of renal failure, accounting for 20% of patients starting dialysis. In clinical trials, effective blood-pressure control,…”
Get full text